EndoRotor for Refractory Dysplastic Barrett's Esophagus

About Interscope

Interscope is a commercial-stage medical device company focused on advanced endoscopic resection tools. Its flagship product, the EndoRotor®, is a single device that simultaneously dissects, resects, and collects tissue, offering a novel approach for procedures like pancreatic necrosectomy and the treatment of difficult gastrointestinal lesions. The device holds both a 510(k) clearance for Endoscopic Powered Resection (EPR) and a De Novo authorization for Powered Endoscopic Debridement (PED) in the US, positioning it as a specialized tool for complex interventional gastroenterology. The company is actively conducting clinical studies to expand the device's indications, including for refractory dysplastic Barrett's esophagus.

Therapeutic Areas